# A Study in Healthy Men to Test How BI 456906 is Processed in the Body

> **NCT05421338** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 456906 (C-14)

## Key facts

- **NCT ID:** NCT05421338
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-04
- **Primary completion:** 2022-11-17
- **Final completion:** 2022-11-17
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05421338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05421338, "A Study in Healthy Men to Test How BI 456906 is Processed in the Body". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT05421338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*